Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.

Williams J, Steers WN, Ettner SL, Mangione CM, Duru OK.

Med Care. 2013 Feb;51(2):193-8. doi: 10.1097/MLR.0b013e318270dc52.

2.

Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.

Sacks NC, Burgess JF Jr, Cabral HJ, Pizer SD, McDonnell ME.

J Gen Intern Med. 2013 Jul;28(7):876-85. doi: 10.1007/s11606-013-2342-3. Epub 2013 Feb 13.

3.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

4.

Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.

Duru OK, Mangione CM, Hsu J, Steers WN, Quiter E, Turk N, Ettner SL, Schmittdiel JA, Tseng CW.

J Am Geriatr Soc. 2010 May;58(5):822-8. doi: 10.1111/j.1532-5415.2010.02813.x. Epub 2010 Apr 6.

5.

Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.

Stuart B, Yin X, Davidoff A, Simoni-Wastila L, Zuckerman I, Shoemaker JS, Doshi J.

Med Care. 2012 Nov;50(11):913-9. doi: 10.1097/MLR.0b013e31826c85f9.

PMID:
23047779
6.

Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM.

Med Care. 2014 Nov;52(11):951-6. doi: 10.1097/MLR.0000000000000205.

7.

The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.

Wei II, Lloyd JT, Shrank WH.

J Am Geriatr Soc. 2013 Aug;61(8):1315-23. doi: 10.1111/jgs.12364. Epub 2013 Jul 26.

PMID:
23889465
8.

Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D.

Zivin K, Madden JM, Graves AJ, Zhang F, Soumerai SB.

Am J Geriatr Psychiatry. 2009 Dec;17(12):1068-76. doi: 10.1097/JGP.0b013e3181b972d1.

9.

Geographic variation in medication adherence in commercial and Medicare part D populations.

Couto JE, Panchal JM, Lal LS, Bunz TJ, Maesner JE, O'Brien T, Khan T.

J Manag Care Spec Pharm. 2014 Aug;20(8):834-42.

10.

Recent trends in cost-related medication nonadherence among stroke survivors in the United States.

Levine DA, Morgenstern LB, Langa KM, Piette JD, Rogers MA, Karve SJ.

Ann Neurol. 2013 Feb;73(2):180-8. doi: 10.1002/ana.23823. Epub 2013 Feb 22.

11.

Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.

Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA.

Ann Intern Med. 2012 Jun 5;156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. doi: 10.7326/0003-4819-156-11-201206050-00004.

PMID:
22665815
12.

Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension.

Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, Shorr RI, Bauer DC, Donohue JM, Hanlon JT; Health ABC Study.

Res Social Adm Pharm. 2013 Nov-Dec;9(6):817-27. doi: 10.1016/j.sapharm.2012.12.002. Epub 2013 Jan 4.

13.

Medicare Part D coverage gap: race, gender, and cost-related medication nonadherence.

Bakk L.

Soc Work Public Health. 2015;30(6):473-85. doi: 10.1080/19371918.2015.1052607. Epub 2015 Aug 6.

PMID:
26247585
14.

Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.

Iyengar RN, LeFrancois AL, Henderson RR, Rabbitt RM.

J Manag Care Spec Pharm. 2016 May;22(5):550-60. doi: 10.18553/jmcp.2016.22.5.550.

15.

Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.

Adams AS, Madden JM, Zhang F, Soumerai SB, Gilden D, Griggs J, Trinacty CM, Bishop C, Ross-Degnan D.

Med Care. 2014 Aug;52(8):695-703. doi: 10.1097/MLR.0000000000000159.

16.

Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.

Frankenfield DL, Howell BL, Wei II, Anderson KK.

Am J Health Syst Pharm. 2011 Jul 15;68(14):1339-48. doi: 10.2146/ajhp100400.

PMID:
21719594
17.

Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, Gurwitz JH, Pierre-Jacques M, Safran DG, Adler GS, Soumerai SB.

JAMA. 2008 Apr 23;299(16):1922-8. doi: 10.1001/jama.299.16.1922.

18.

The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.

Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP.

Med Care. 2010 May;48(5):409-17. doi: 10.1097/MLR.0b013e3181d68978.

PMID:
20393360
19.

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2014 Aug;20(8):862-76.

20.

Did Medicare Part D reduce disparities?

Zissimopoulos J, Joyce GF, Scarpati LM, Goldman DP.

Am J Manag Care. 2015 Feb;21(2):119-28.

Supplemental Content

Support Center